Analysis of the therapeutic effect and influencing factors on unresectable gastric cancer treated with conversion therapy.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
160 patients with AUGC.
I · Intervention 중재 / 시술
conversion therapy from this center and designed a retrospective study
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
추출되지 않음
[BACKGROUND] Gastric cancer (GC) is one of the leading causes of cancer-related death in China, and with the extensive development of conversion therapy, the treatment of advanced unresectable gastric
- 95% CI 1.013-1.081
- OR 1.046
APA
Han S, Han S, et al. (2024). Analysis of the therapeutic effect and influencing factors on unresectable gastric cancer treated with conversion therapy.. Frontiers in oncology, 14, 1435398. https://doi.org/10.3389/fonc.2024.1435398
MLA
Han S, et al.. "Analysis of the therapeutic effect and influencing factors on unresectable gastric cancer treated with conversion therapy.." Frontiers in oncology, vol. 14, 2024, pp. 1435398.
PMID
39540147 ↗
Abstract 한글 요약
[BACKGROUND] Gastric cancer (GC) is one of the leading causes of cancer-related death in China, and with the extensive development of conversion therapy, the treatment of advanced unresectable gastric cancer (AUGC) patients has ushered in a new dawn. This study aimed to analyze the efficacy of conversion therapy in AUGC patients and explored the relevant factors affecting the efficacy.
[METHOD] We collected information from GC patients who received conversion therapy from this center and designed a retrospective study.
[RESULTS] We collected relevant clinical data from 160 patients with AUGC. A total of 120 patients who underwent routine R0 resection were identified as conversion cases. A total of 25 patients (15.6%) achieved pCR, 92 patients (57.5%) achieved objective response rate (ORR), 140 patients (87.5%) achieved disease control rate (DCR), and 20 cases (12.5%) observed tumor progression. There were 86 patients who achieved pathological downgrading, with a total downgrading rate of 53.8%. Among the 160 patients, 37 patients (23.1%) had postoperative complications of varying degrees. A total of 72 patients (45.0%) had tumor recurrence/progression at the end of follow-up. The last chemotherapy and surgery (CST) (OR = 1.046, 95% CI 1.013-1.081, = 0.006), tumor invasion (OR = 32.096, 95% CI 5.091-202.349, < 0.001), and distant metastasis (OR = 7.050, 95% CI 1.888-26.323, = 0.004) were independent factors influencing the efficacy of conversion therapy.
[CONCLUSION] Conversion therapy may have a good therapeutic efficacy for AUGC, and some clinical factors affect the efficacy response.
[METHOD] We collected information from GC patients who received conversion therapy from this center and designed a retrospective study.
[RESULTS] We collected relevant clinical data from 160 patients with AUGC. A total of 120 patients who underwent routine R0 resection were identified as conversion cases. A total of 25 patients (15.6%) achieved pCR, 92 patients (57.5%) achieved objective response rate (ORR), 140 patients (87.5%) achieved disease control rate (DCR), and 20 cases (12.5%) observed tumor progression. There were 86 patients who achieved pathological downgrading, with a total downgrading rate of 53.8%. Among the 160 patients, 37 patients (23.1%) had postoperative complications of varying degrees. A total of 72 patients (45.0%) had tumor recurrence/progression at the end of follow-up. The last chemotherapy and surgery (CST) (OR = 1.046, 95% CI 1.013-1.081, = 0.006), tumor invasion (OR = 32.096, 95% CI 5.091-202.349, < 0.001), and distant metastasis (OR = 7.050, 95% CI 1.888-26.323, = 0.004) were independent factors influencing the efficacy of conversion therapy.
[CONCLUSION] Conversion therapy may have a good therapeutic efficacy for AUGC, and some clinical factors affect the efficacy response.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Vascular Pedicle Ossification After Jaw Reconstruction With Fibular Free Flap.
- Risk Factor Profiles and Elevated Incidence of Pancreatic Cancer in Native Hawaiians.
- Prediction Model of Ki67 Proliferation Level in Hepatocellular Carcinoma Based on Contrast-Enhanced Ultrasound.
- Dairy products and their key nutrients as protective factors against colorectal cancer risk: The Multiethnic Cohort.
- Intraoral Anastomosis of Free Fibular Flap for Reconstruction of Maxillofacial Defect.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Impact of Comorbidities on Clinical Outcomes and Quality of Life of Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer Treated With Palbociclib in the POLARIS Study.
- Key Considerations for Targeting in Pancreatic Cancer: Potential Impact on the Treatment Paradigm.
- Overcoming Chemoresistance in Glioblastoma: Mechanisms, Therapeutic Strategies, and Functional Precision Medicine.
- Current Systemic Treatment Options for Advanced Pancreatic Cancer-An Overview Article.
- Balancing safety and efficacy of Bendamustine plus anti CD20 regimens in elderly patients (> 70 y) with follicular lymphoma: a tertiary academic center experience.